FDA Approves GlaxoSmithKline Drug for Treatment of Anthrax :: Editor's Blog at …
FDA approves GlaxoSmithKline drug for treatment of anthrax :: Editor's Blog at …
Filed under: drug rehab treatment options
Research Triangle Park, N.C. — Federal health officials say they approved a new injectable drug from Human Genome Sciences to treat inhalable anthrax. HGS is now part of GlaxoSmithKline (NYSE: GSK). The Food and Drug Administration says …
Read more on WRAL Tech Wire
Acute mononucleosis rarely recurs
Filed under: drug rehab treatment options
Dear Drs. Donohue and Roach: I'm writing in reference to the antibiotic drug Levaquin. I contracted bronchitis in January 2012 and was treated with this drug, and it gave me tendonitis of my left Achilles' tendon. In July 2012, my tendon ruptured. I've …
Read more on The Detroit News
FDA Accepts NDA for Pulmonary Arterial Hypertension Drug Opsumit
Filed under: drug rehab treatment options
Actelion announced that the FDA has officially accepted the New Drug Application (NDA) for macitentan (Opsumit) for the treatment of patients with pulmonary arterial hypertension. Macitentan is a novel dual endothelin receptor antagonist. Opsumit was …
Read more on Monthly Prescribing Reference